The prize of prizes: mRNA research paving the way for COVID‐19 vaccine success wins the Nobel Prize in Physiology or Medicine 2023

Scandinavian Journal of ImmunologyVolume 98, Issue 6 e13340 EDITORIAL The prize of prizes: mRNA research paving the way for COVID-19 vaccine success wins the Nobel Prize in Physiology or Medicine 2023 Marcus Buggert, Corresponding Author Marcus Buggert [email protected] Center for Infectious Medicine (CIM), Department of Medicine Huddinge, Karolinska Institutet, Stockholm, SwedenSearch for more papers by this authorPetter Höglund, Petter Höglund Center for hematology and Regenerative Medicine (HERM), Department of Medicine Huddinge, Karolinska Institutet, Stockholm, SwedenSearch for more papers by this author Marcus Buggert, Corresponding Author Marcus Buggert [email protected] Center for Infectious Medicine (CIM), Department of Medicine Huddinge, Karolinska Institutet, Stockholm, SwedenSearch for more papers by this authorPetter Höglund, Petter Höglund Center for hematology and Regenerative Medicine (HERM), Department of Medicine Huddinge, Karolinska Institutet, Stockholm, SwedenSearch for more papers by this author First published: 12 November 2023 https://doi.org/10.1111/sji.13340Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. REFERENCES 1Carlson KN, Verhagen JC, Jennings H, et al. Single-cell RNA sequencing distinguishes dendritic cell subsets in the rat, allowing advanced characterization of the effects of FMS-like tyrosine kinase 3 ligand. Scand J Immunol. 2022 Jul; 96:e13159. 2Kariko K, Buckstein M, Ni H, Weissman D. Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. Immunity. 2005 Aug; 23: 165-175. 3Anderson BR, Muramatsu H, Nallagatla SR, et al. Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation. Nucleic Acids Res. 2010 Sep; 38: 5884-5892. 4Barbier AJ, Jiang AY, Zhang P, Wooster R, Anderson DG. The clinical progress of mRNA vaccines and immunotherapies. Nat Biotechnol. 2022 Jun; 40: 840-854. 5Rurik JG, Tombacz I, Yadegari A, et al. CAR T cells produced in vivo to treat cardiac injury. Science. 2022 Jan; 7(375): 91-96. Volume98, Issue6December 2023e13340 ReferencesRelatedInformation